Effects of N-acetylcysteine, deferoxamine and selenium on doxorubicin-induced hepatotoxicity
F Bulucu, R Ocal, N Karadurmus, M Sahin… - Biological trace element …, 2009 - Springer
The aims of our study were to evaluate the antioxidant defence mechanisms of liver tissue
challenged by doxorubucin (DOX) and to compare the possible protective effects of N-…
challenged by doxorubucin (DOX) and to compare the possible protective effects of N-…
Can mainstream end-tidal carbon dioxide measurement accurately predict the arterial carbon dioxide level of patients with acute dyspnea in ED
OBJECTIVE: This study was designed to determine whether the mainstream end-tidal carbon
dioxide (ETCO 2 ) measurement can accurately predict the partial arterial carbon dioxide (…
dioxide (ETCO 2 ) measurement can accurately predict the partial arterial carbon dioxide (…
Epidemiology of allergic rhinitis
R Öçal, N Bayar Muluk, J Mullol - All Around the Nose: Basic Science …, 2020 - Springer
Allergic rhinitis (AR) is a worldwide health-related issue having an effect on 10–20% of the
entire population, hence causing AR to be the most prevalent chronic non-communicable …
entire population, hence causing AR to be the most prevalent chronic non-communicable …
[HTML][HTML] Ursodeoxycholic acid treatment improves hepatocyte ultrastructure in rat liver fibrosis
AIM: To examine the ultrastructural changes after ursodeoxycholic acid (UDCA) treatment in
hepatocytes from experimentally induced fibrotic livers. METHODS: Liver fibrosis was …
hepatocytes from experimentally induced fibrotic livers. METHODS: Liver fibrosis was …
[HTML][HTML] Is the C-reactive protein/albumin ratio a prognostic and predictive factor in sudden hearing loss?
R Öçal, FC Akın Öçal, M Güllüev… - Brazilian Journal of …, 2020 - SciELO Brasil
SciELO - Brasil - Is the C-reactive protein/albumin ratio a prognostic and predictive factor in
sudden hearing loss? Is the C-reactive protein/albumin ratio a prognostic and predictive …
sudden hearing loss? Is the C-reactive protein/albumin ratio a prognostic and predictive …
[PDF][PDF] Long-term Results of Imatinib Discontinuation in Patients with Chronic-phase Chronic Myeloid Leukemia: A National Multicenter Prospective Study
…, AAB Dikyar, ZN Özkurt, R Öcal… - Turkish Journal of …, 2023 - jag.journalagent.com
Objective: The discovery of imatinib was a milestone for chronic myeloid leukemia (CML).
As the life expectancy of CML patients has approached that of the general population, …
As the life expectancy of CML patients has approached that of the general population, …
Effect of probiotics in experimental otitis media with effusion
SK Kaytez, R Ocal, N Yumusak, H Celik… - International Journal of …, 2020 - Elsevier
… Author links open overlay panel Selda Kargin Kaytez a , Ramazan Ocal a , Nihat
Yumusak b , Hatiçe Celik a , Necmi Arslan a , Mustafa Ibas a …
Yumusak b , Hatiçe Celik a , Necmi Arslan a , Mustafa Ibas a …
Is there any effect of montelukast on prevention of myringosclerosis after myringotomy in a rat model?
S Kargin Kaytez, A Kavuzlu, N Yumusak, R Oçal… - European Archives of …, 2019 - Springer
Objectives In this study, our aim was to identify the possible effects of montelukast sodium (ML)
on the prevention of experimentally induced myringosclerosis. Materials and methods …
on the prevention of experimentally induced myringosclerosis. Materials and methods …
Adiponectin and insulin resistance in young and healthy smokers
Smoking is closely associated with insulin resistance, though the mechanism is not clear.
Adiponectin, a novel anti-atherosclerotic and anti-inflammatory adipose tissue product, which …
Adiponectin, a novel anti-atherosclerotic and anti-inflammatory adipose tissue product, which …
The effect of radiologic imaging studies on the risk of secondary malignancy development in patients with Hodgkin lymphoma
Purpose Recently, reports have been published, which suggest that diagnostic radiologic
imaging studies could play a role in the risk of secondary malignancy development in patients …
imaging studies could play a role in the risk of secondary malignancy development in patients …